Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
MAIA Biotechnology Inc (AMEX: MAIA) closed the day trading at $2.89 down -4.93% from the previous closing price of $3.04. In other words, the price has decreased by -$4.93 from its previous closing price. On the day, 0.57 million shares were traded. MAIA stock price reached its highest trading level at $3.102 during the session, while it also had its lowest trading level at $2.85.
Ratios:
For a better understanding of MAIA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 25 ’24 when Smith Stan bought 147,492 shares for $2.03 per share. The transaction valued at 299,409 led to the insider holds 1,005,060 shares of the business.
Louie Ngar Yee bought 19,665 shares of MAIA for $39,920 on Apr 25 ’24. The Director now owns 1,167,189 shares after completing the transaction at $2.03 per share. On Mar 14 ’24, another insider, Smith Stan, who serves as the Director of the company, bought 170,940 shares for $1.17 each. As a result, the insider paid 200,000 and bolstered with 857,568 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MAIA now has a Market Capitalization of 59480536 and an Enterprise Value of 53657896.
Stock Price History:
The Beta on a monthly basis for MAIA is 0.08, which has changed by 0.19215691 over the last 52 weeks, in comparison to a change of 0.25590587 over the same period for the S&P500. Over the past 52 weeks, MAIA has reached a high of $3.59, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 32.94%, while the 200-Day Moving Average is calculated to be 62.11%.
Shares Statistics:
Over the past 3-months, MAIA traded about 368.34K shares per day on average, while over the past 10 days, MAIA traded about 393730 shares per day. A total of 16.99M shares are outstanding, with a floating share count of 16.03M. Insiders hold about 22.12% of the company’s shares, while institutions hold 3.85% stake in the company. Shares short for MAIA as of 1713139200 were 785175 with a Short Ratio of 2.13, compared to 1710460800 on 508511. Therefore, it implies a Short% of Shares Outstanding of 785175 and a Short% of Float of 4.7.
Earnings Estimates
A detailed examination of MAIA Biotechnology Inc (MAIA) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.33 and a low estimate of -$0.45, while EPS last year was -$0.38. The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.33 and low estimates of -$0.5.
Analysts are recommending an EPS of between -$1.25 and -$1.92 for the fiscal current year, implying an average EPS of -$1.58.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $35.38M in the next fiscal year. The high estimate is $35.38M and the low estimate is $35.38M.
